On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
We have now added a new section called the "Assay History List" to the "At A Gla...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...